By contrast, basal ASCL1 expression remained persistently elevated post-AD upon reintroduction of R1881 (Fig. 6C) and was further elevated by a subsequent round of AD (AD2, Fig. 6D). Here, ASCL1 is linked to Alzheimer disease.